AstraZeneca signs MoU with RSSDI to empower 1 crore Indian diabetic patients by 2023
With close to 8 Crore diabetes patients in India, the need for building awareness and research-based effort to provide the much-needed support for early detection and treatment of Diabetes will go a long way in decreasing the uncontrolled incidence of the disease and associated complications